Geneos Wealth Management’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55K Hold
538
– – ﹤0.01% 1423
2026
Q1
$42.3K Hold
538
– – ﹤0.01% 1491
2025
Q4
$39.1K Sell
538
-126
-19% -$8.94K ﹤0.01% 1488
2025
Q3
$44.8K Sell
664
-29
-4% -$1.87K ﹤0.01% 1428
2025
Q2
$43.8K Buy
693
+269
+63% +$15.7K ﹤0.01% 1641
2025
Q1
$23.4K Sell
424
-115
-21% -$6.45K ﹤0.01% 1876
2024
Q4
$29.9K Buy
539
+335
+164% +$19.7K ﹤0.01% 1541
2024
Q3
$12.5K Buy
+204
New +$12.2K ﹤0.01% 1751
2023
Q4
– Sell
-40
Closed -$1.99K – 2114
2023
Q3
$1.99K Buy
+40
New +$2.08K ﹤0.01% 1940
2022
Q4
– Sell
-59
Closed -$2K – 2038
2022
Q3
$2K Buy
+59
New +$2.87K ﹤0.01% 1831

Other funds holding EMXC

Geneos Wealth Management's EMXC Position: Q2 2026 in Review

Geneos Wealth Management held its iShares MSCI Emerging Markets ex China ETF (EMXC) position steady in Q2 2026 at 538 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Geneos Wealth Management first reported a position in EMXC in Q3 2022 and has held it in 10 quarters since. 1,025 funds tracked by Wall St. Rank hold EMXC as of Q2 2026.

  • Geneos Wealth Management held 538 shares of iShares MSCI Emerging Markets ex China ETF worth $55K as of Q2 2026.
  • Geneos Wealth Management left its iShares MSCI Emerging Markets ex China ETF share count unchanged in Q2 2026.
  • iShares MSCI Emerging Markets ex China ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1423 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI Emerging Markets ex China ETF in Q3 2022 and has held it in 10 quarters since.
  • 1,025 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.